Home/Filings/4/0000950170-24-131938
4//SEC Filing

Rothfuss Cristin 4

Accession 0000950170-24-131938

CIK 0000873303other

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 8:15 PM ET

Size

7.4 KB

Accession

0000950170-24-131938

Insider Transaction Report

Form 4
Period: 2024-11-26
Rothfuss Cristin
EVP, General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2024-11-26+4,0004,000 total
    Exercise: $130.50From: 2025-11-26Exp: 2034-11-26Common Stock (4,000 underlying)
  • Award

    Common Stock

    2024-11-26+2,00013,817 total
Footnotes (2)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
  • [F2]Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.

Documents

1 file

Issuer

Sarepta Therapeutics, Inc.

CIK 0000873303

Entity typeother

Related Parties

1
  • filerCIK 0002046214

Filing Metadata

Form type
4
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 8:15 PM ET
Size
7.4 KB